Amgen reported $1.23B in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
ALKERMES ALKS:US 145.05M 15.36M
Amgen AMGN:US $ 1.23B 197M
Astrazeneca AZN:US 3.06B 1.03B
Biogen BIIB:US $ 634.9M 153M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Coherus Biosciences CHRS:US $ 48.75M 1.3M
Eli Lilly And LLY:US $ 1.56B 34.1M
Exelixis EXEL:US $ 102.86M 3.55M
Genmab GEN:DC 452M 60M
Gilead Sciences GILD:US $ 1.08B 567M
Glaxosmithkline GSK:US 2.68B 227M
GlaxoSmithKline GSK:LN 2.68B 227M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Merk MRK:US $ 2.3B 518M
Mirati Therapeutics MRTX:US $ 53.95M 10.42M
Moderna Inc MRNA:US 268M 67M
Novartis NVS:US 3.5B 486M
Novartis NOVN:VX 3.5B 486M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Takeda 4502:JP 223.43B 7.65B
Teva Pharmaceutical TEVA:IT 819M 39M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M
YTE INCY:US $ 209.58M 16.62M